Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
Publication date: Available online 19 March 2021Source: Redox BiologyAuthor(s): Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Jorrit De Waele, Christophe Hermans, Hilde Lambrechts, Bart Cuypers, Kris Laukens, Esther Bartholomeus, Vasiliki Siozopoulou, Winnok H. De Vos, Marc Peeters, Evelien L.J. Smits, Christophe Deben
Source: Redox Biology - Category: Biology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Lung Cancer | Molecular Biology | Non-Small Cell Lung Cancer